HashiCorp (HCP) 10-Q 31 Aug 23 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2023	Aug. 25, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2023
Document Transition Report	false
Entity File Number	001-41121
Entity Registrant Name	HashiCorp, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	32-0410665
Entity Address, Address Line One	101 Second Street
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	(415)
Local Phone Number	301-3250
Title of 12(b) Security	Class A Common Stock, par value $0.000015 per share
Trading Symbol	HCP
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001720671
Document Fiscal Period Focus	Q2
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Common Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		109,376,687
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		84,511,053

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 830,018	$ 1,286,134
Short-term investments	414,094	0
Accounts receivable, net of allowance	122,385	162,369
Deferred contract acquisition costs	45,329	42,812
Prepaid expenses and other current assets	28,526	17,683
Total current assets	1,440,352	1,508,998
Deferred contract acquisition costs, non-current	82,921	81,286
Acquisition-related intangible assets, net	13,028	0
Goodwill	12,265	0
Other assets, non-current	42,037	38,056
Total assets	1,590,603	1,628,340
Current liabilities:
Accounts payable	7,693	12,450
Accrued expenses and other current liabilities	10,376	10,163
Accrued compensation and benefits	53,505	58,628
Deferred revenue	264,639	272,909
Customer deposits	25,564	26,699
Total current liabilities	361,777	380,849
Deferred revenue, non-current	28,802	29,335
Other liabilities, non-current	15,112	12,806
Total liabilities	405,691	422,990
Commitments and contingencies (Note 11)
Stockholders’ equity:
Additional paid-in capital	2,085,910	1,985,747
Accumulated other comprehensive loss	(1,028)	0
Accumulated deficit	(899,973)	(780,400)
Total stockholders’ equity	1,184,912	1,205,350
Total liabilities and stockholders’ equity	1,590,603	1,628,340
Class A Common Stock
Stockholders’ equity:
Common stock	1	1
Class B Common Stock
Stockholders’ equity:
Common stock	$ 2	$ 2

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jul. 31, 2023	Jan. 31, 2023
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.000015	$ 0.000015
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	109,085,000	88,823,000
Common stock, shares outstanding (in shares)	109,085,000	88,823,000
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.000015	$ 0.000015
Common stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, shares issued (in shares)	84,561,000	101,145,000
Common stock, shares outstanding (in shares)	84,561,000	101,145,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenue:
Total revenue	$ 143,246	$ 113,863	$ 281,229	$ 214,760
Cost of revenue:
Total cost of revenue	29,334	21,540	56,122	40,929
Gross profit	113,912	92,323	225,107	173,831
Operating expenses:
Sales and marketing	101,134	87,674	191,698	167,926
Research and development	59,962	47,885	114,155	95,060
General and administrative	35,412	35,383	69,660	67,906
Total operating expenses	196,508	170,942	375,513	330,892
Loss from operations	(82,596)	(78,619)	(150,406)	(157,061)
Interest income	16,300	3,926	31,280	4,542
Other income (expense), net	(105)	66	(225)	(40)
Loss before income taxes	(66,401)	(74,627)	(119,351)	(152,559)
Provision (benefit) for income taxes	(86)	137	222	422
Net loss	$ (66,315)	$ (74,764)	$ (119,573)	$ (152,981)
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)	$ (0.34)	$ (0.40)	$ (0.62)	$ (0.83)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)	$ (0.34)	$ (0.40)	$ (0.62)	$ (0.83)
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	192,610	185,212	191,723	184,114
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	192,610	185,212	191,723	184,114
Subscription revenue
Revenue:
Total revenue	$ 139,093	$ 110,232	$ 272,708	$ 208,616
Cost of revenue:
Total cost of revenue	24,421	18,331	46,877	34,392
Subscription revenue | License
Revenue:
Total revenue	16,724	15,338	31,882	25,682
Cost of revenue:
Total cost of revenue	498	360	1,083	753
Subscription revenue | Support
Revenue:
Total revenue	103,997	84,257	205,910	163,465
Cost of revenue:
Total cost of revenue	16,304	12,272	31,147	23,110
Subscription revenue | Cloud-hosted services
Revenue:
Total revenue	18,372	10,637	34,916	19,469
Cost of revenue:
Total cost of revenue	7,619	5,699	14,647	10,529
Professional services and other
Revenue:
Total revenue	4,153	3,631	8,521	6,144
Cost of revenue:
Total cost of revenue	$ 4,913	$ 3,209	$ 9,245	$ 6,537

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (66,315)	$ (74,764)	$ (119,573)	$ (152,981)
Available-for-sale investments:
Unrealized losses on available-for-sale investments	(867)	0	(933)	0
Foreign currency forward contracts:
Unrealized losses on foreign currency forward contracts	(95)	0	(95)	0
Other comprehensive loss, net of tax	(962)	0	(1,028)	0
Total comprehensive loss	$ (67,277)	$ (74,764)	$ (120,601)	$ (152,981)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Class A and Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2022		182,167,000
Beginning balance at Jan. 31, 2022	$ 1,282,291	$ 3	$ 1,788,390		$ (506,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		839,000
Issuance of common stock upon exercise of stock options	521		521
Vesting of early exercised stock options	3		3
Issuance of common stock upon settlement of restricted stock units (in shares)		710,000
Tax withholdings on settlement of restricted stock units (in shares)		(8,000)
Tax withholdings on settlement of restricted stock units	(125)		(125)
Stock-based compensation	47,141		47,141
Net loss	(78,217)				(78,217)
Ending balance (in shares) at Apr. 30, 2022		183,708,000
Ending balance at Apr. 30, 2022	1,251,614	$ 3	1,835,930		(584,319)
Beginning balance (in shares) at Jan. 31, 2022		182,167,000
Beginning balance at Jan. 31, 2022	1,282,291	$ 3	1,788,390		(506,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	0
Net loss	(152,981)
Ending balance (in shares) at Jul. 31, 2022		186,320,000
Ending balance at Jul. 31, 2022	1,230,230	$ 3	1,889,310		(659,083)
Beginning balance (in shares) at Apr. 30, 2022		183,708,000
Beginning balance at Apr. 30, 2022	1,251,614	$ 3	1,835,930		(584,319)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		786,000
Issuance of common stock upon exercise of stock options	1,645		1,645
Vesting of early exercised stock options	2		2
Issuance of common stock upon settlement of restricted stock units (in shares)		1,477,000
Tax withholdings on settlement of restricted stock units (in shares)		(2,000)
Tax withholdings on settlement of restricted stock units	(77)		(77)
Issuance of common stock under employee stock purchase plan (in shares)		351,000
Issuance of common stock under employee stock purchase plan	8,501		8,501
Stock-based compensation	43,309		43,309
Other comprehensive loss	0
Net loss	(74,764)				(74,764)
Ending balance (in shares) at Jul. 31, 2022		186,320,000
Ending balance at Jul. 31, 2022	1,230,230	$ 3	1,889,310		(659,083)
Beginning balance (in shares) at Jan. 31, 2023		189,968,000
Beginning balance at Jan. 31, 2023	1,205,350	$ 3	1,985,747	$ 0	(780,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		513,000
Issuance of common stock upon exercise of stock options	1,013		1,013
Issuance of common stock upon settlement of restricted stock units (in shares)		1,071,000
Tax withholdings on settlement of restricted stock units	(9)		(9)
Stock-based compensation	41,266		41,266
Other comprehensive loss	(66)			(66)
Net loss	(53,258)				(53,258)
Ending balance (in shares) at Apr. 30, 2023		191,552,000
Ending balance at Apr. 30, 2023	1,194,296	$ 3	2,028,017	(66)	(833,658)
Beginning balance (in shares) at Jan. 31, 2023		189,968,000
Beginning balance at Jan. 31, 2023	1,205,350	$ 3	1,985,747	0	(780,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	(1,028)
Net loss	(119,573)
Ending balance (in shares) at Jul. 31, 2023		193,646,000
Ending balance at Jul. 31, 2023	1,184,912	$ 3	2,085,910	(1,028)	(899,973)
Beginning balance (in shares) at Apr. 30, 2023		191,552,000
Beginning balance at Apr. 30, 2023	1,194,296	$ 3	2,028,017	(66)	(833,658)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		366,000
Issuance of common stock upon exercise of stock options	442		442
Issuance of common stock upon settlement of restricted stock units (in shares)		1,307,000
Tax withholdings on settlement of restricted stock units (in shares)		(5,000)
Tax withholdings on settlement of restricted stock units	(215)		(215)
Issuance of common stock under employee stock purchase plan (in shares)		426,000
Issuance of common stock under employee stock purchase plan	10,195		10,195
Stock-based compensation	47,471		47,471
Other comprehensive loss	(962)			(962)
Net loss	(66,315)				(66,315)
Ending balance (in shares) at Jul. 31, 2023		193,646,000
Ending balance at Jul. 31, 2023	$ 1,184,912	$ 3	$ 2,085,910	$ (1,028)	$ (899,973)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Cash flows from operating activities
Net loss	$ (119,573)	$ (152,981)
Adjustments to reconcile net loss to cash from operating activities:
Stock-based compensation expense, net of amounts capitalized	86,282	88,662
Depreciation and amortization expense	3,876	1,947
Non-cash operating lease cost	1,474	1,416
Accretion of discounts on marketable securities	(4,196)	0
Deferred income taxes	(482)	0
Other	68	(19)
Changes in operating assets and liabilities:
Accounts receivable	39,914	15,227
Deferred contract acquisition costs	(4,152)	(19,688)
Prepaid expenses and other assets	(11,161)	(1,175)
Accounts payable	(5,007)	(3,044)
Accrued expenses and other liabilities	(1,776)	(1,741)
Accrued compensation and benefits	(5,123)	(1,961)
Deferred revenue	(8,803)	3,523
Customer deposits	(1,135)	(1,035)
Net cash used in operating activities	(29,794)	(70,869)
Cash flows from investing activities
Business combination, net of cash acquired	(20,859)	0
Purchases of property and equipment	(417)	(72)
Capitalized internal-use software	(5,669)	(3,516)
Purchases of short-term investments	(469,704)	0
Proceeds from sales of short-term investments	26,372	0
Proceeds from maturities of short-term investments	32,529	0
Net cash used in investing activities	(437,748)	(3,588)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards	(224)	(202)
Proceeds from issuance of common stock upon exercise of stock options	1,455	2,166
Proceeds from issuance of common stock under employee stock purchase plan	10,195	8,501
Net cash provided by financing activities	11,426	10,465
Net decrease in cash and cash equivalents, and restricted cash	(456,116)	(63,992)
Cash and cash equivalents, and restricted cash beginning of period	1,286,134	1,357,613
Cash and cash equivalents, and restricted cash end of period	830,018	1,293,621
Supplemental disclosure of cash flow information
Cash paid for income taxes, net of refunds received	784	408
Cash paid for operating lease liabilities	1,930	1,874
Supplemental disclosure of noncash investing and financing activities
Capitalized stock-based compensation expense	2,455	1,788
Acquisition holdback	$ 4,200	$ 0

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business Description of Business

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America ("U.S. GAAP" or "GAAP") and include the accounts of the Company and its wholly owned subsidiaries. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (the "SEC"). The condensed balance sheet data as of January 31, 2023 was derived from the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “2023 Form 10-K”), but does not include all disclosures required by U.S. GAAP. Therefore, these interim condensed consolidated financial statements and accom panying footnotes should be read in conjunction with the Company’s annual consolidated financial statements and related footnotes included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “fiscal 2023 Form 10-K”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, that are, in the opinion of management, necessary for the fair presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity for the interim periods presented. The results of operations for the three and six months ended July 31, 2023 shown in this report are not necessarily indicative of the results to be expected for the full year ending January 31, 2024 or any other period. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting period. Such management estimates include, but are not limited to, the determination of standalone selling prices of the Company’s performance obligations, the estimated period of benefit of deferred contract acquisition costs, the fair value of share-based awards, software development costs, discount rates used for operating leases, goodwill and acquisition-related intangible assets, and the valuation allowance on deferred tax assets and uncertain tax positions. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates. Accumulated Other Comprehensive Loss As of July 31, 2023, accumulated other comprehensive loss was comprised of unrealized losses from available-for-sale investments and unrealized losses related to the effective portion of changes in the fair value of foreign currency forward contracts designated as cash flow hedges. Impairment of Long-Lived Assets Long-lived assets, such as property and equipment, acquired intangible assets, and capitalized software development costs subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If circumstances require a long-lived asset be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by the asset to its carrying value. If the carrying value of the long-lived asset is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary. For the fiscal years presented, there were no impairment losses recognized for any long-lived assets. Significant Accounting Policies Other than the business combinations, goodwill, short-term investments and derivative instruments and hedging policies described below, there have been no changes to the Company’s significant accounting policies described in the fiscal 2023 Form 10-K that have had a material impact on these condensed consolidated financial statements and related notes. Business Combinations The Company recognizes identifiable assets acquired and liabilities assumed at their acquisition date fair value. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions as a part of the purchase price allocation process to accurately value assets acquired and liabilities assumed at the acquisition date, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill to the extent that the Company identifies adjustments to the preliminary purchase price allocation. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s consolidated statements of operations. There has been no such adjustment as of July 31, 2023. Goodwill Goodwill represents the excess of the purchase price of an acquired business over the fair value of the underlying net tangible and intangible assets. Goodwill is evaluated for impairment annually in the fourth quarter of the Company’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill, or a significant decrease in expected cash flows. As of July 31, 2023, the Company has not had any goodwill impairments. Short-term Investments The Company’s short-term investments consist of U.S. treasury securities, corporate notes and bonds, U.S. agency obligations, commercial paper, and certificates of deposit. The Company determines the appropriate classification of its short-term investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company has classified and accounted for its short-term investments as available-for-sale securities. The Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its short-term investments, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. Available-for-sale securities are recorded at fair value each reporting period, and are adjusted for amortization of premiums and accretion of discounts to maturity and such amortization and accretion are included in interest income in the condensed consolidated statements of operations. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the condensed consolidated statements of operations. Unrealized gains are reported as a separate component of accumulated other comprehensive loss on the condensed consolidated balance sheets until realized. For available-for-sale securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the condensed consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the condensed consolidated balance sheets with a corresponding charge in other income (expense), net in the condensed consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive loss. As of July 31, 2023, the Company did not identify any credit losses on short-term investments. Realized gains and losses on the sale of short-term investments are determined on a specific identification method and are recorded in other income (expense), net in the consolidated statements of operations. For the three and six months ended, the realized gains or losses on the sale of short-term investments were not material. Derivative Instruments and Hedging The Company enters into foreign currency forward contracts with certain financial institutions to mitigate the impact of foreign currency fluctuations on future cash flows and earnings. All of the Company’s foreign currency forward contracts are designated as cash flow hedges. The foreign currency forward contracts generally have maturities of 12 months or less. The Company recognizes all forward contracts as either assets or liabilities on the consolidated balance sheets at fair value. Gains and losses on each forward contract are initially reported as a component of accumulated other comprehensive income (loss) (“AOCI”), and subsequently reclassified into cost of revenue or operating expense in the same period, or periods, during which the hedged transaction affects earnings. The Company evaluates the effectiveness of its cash flow hedges on a quarterly basis and does not exclude any component of the changes in fair value of the derivative instruments for effectiveness testing purposes. The Company classifies cash flows related to its cash flow hedges as operating activities in its consolidated statements of cash flows. The Company does not have collateral requirements with any of its counterparties. The Company does not use derivative instruments for trading or speculative purposes.

Business Combinations

Business Combinations	6 Months Ended
	Jul. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	3. Business Combinations On June 2, 2023 (the "Closing"), the Company acquired all outstanding share capital of BluBracket, Inc. (“BluBracket acquisition”). BluBracket is a Palo Alto-based security startup that has developed a code security solution that identifies, prevents, and resolves potential risks in source code, development environments, and pipelines. The Company expects that BluBracket will enable its customers to have full visibility into their entire secrets inventory, complementing Vault's core secrets management solution. The aggregate purchase price was $25.1 million settled in cash (the "Purchase Price") of which the Company is holding back approximately $4.0 million for 14 months after the Closing and $0.2 million within one year following the Closing to satisfy indemnification obligations of BluBracket (the "Holdback"). The Holdback has been accrued as a long-term liability. The purchase price excludes retention agreements entered into with certain employees of BluBracket, pursuant to which the Company will pay up to an aggregate of $5.0 million in cash (the “Retention Payments”). The vesting and payout of the Retention Payments is subject to continued employment and achievement of certain semi-annual milestones over two years following the Closing. The Retention Payment is recorded as post-combination compensation expense within research and development in the condensed consolidated statements of operations over the requisite service period. During the three and six months ended July 31, 2023, the Company recognized compensation expense of $0.4 million related to the Retention Payment agreements. The acquisition was accounted for as a business combination. A portion of the Purchase Price was allocated to the fair value of the developed technology and customer relationship acquired, net liabilities assumed and a deferred tax liability related to developed technology, as set forth below. The useful lives for these acquired developed technology and the customer relationship were estimated to be five The following table presents the purchase price allocation related to the acquisition (in thousands): As of July, 31, 2023 Net liabilities $ (224) Developed technology 12,500 Customer relationship 1,000 Deferred tax liabilities (482) Goodwill 12,265 Total purchase consideration $ 25,059 The estimated fair value of developed technology and customer relationship acquired of $12.5 million and $1.0 million were determined using a replacement cost approach methodology, which is based on the cost that a market participant would incur to reconstruct a substitute asset of comparable utility and generate the acquired portfolio of customers, respectively. The financial results of BluBracket are included in the Company's consolidated financial statements from the date of acquisition. The business combination did not have a material impact on the consolidated financial statements and therefore historical and pro forma disclosures have not been presented.

Goodwill and Acquisition-relate

Goodwill and Acquisition-related Intangible Assets, Net	6 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquisition-related Intangible Assets, Net	4. Goodwill and Acquisition-related Intangible Assets, Net On June 2, 2023, the Company completed the acquisition of BluBracket, Inc. As of the closing of the acquisition, the estimated fair value of the acquired developed technology, customer relationship, and goodwill was $12.5 million, $1.0 million, and $12.3 million, respectively. Goodwill Goodwill as of July 31, 2023 was $12.3 million. No goodwill was recorded as of January 31, 2023. During the six months ended July 31, 2023, changes in goodwill consisted of the following (in thousands): Balance as of January 31, 2023 $ — BluBracket, Inc. (Note 3) 12,265 Balance as of July 31, 2023 $ 12,265 Acquisition-related Intangible Assets, Net Acquisition-related intangible assets, net consisted of the following as of July 31, 2023 (in thousands except for useful life): Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful Life Developed technology $ 12,500 $ 417 $ 12,083 4.8 Customer relationship $ 1,000 $ 55 $ 945 2.8 Acquired intangible assets are recorded at cost, net of accumulated amortization, and are amortized on a straight-line basis over their estimated useful lives. Amortization expense of acquired developed technology was included in cost of cloud-hosted services in the condensed consolidated statements of operations and was $0.5 million for the three and six months ended July 31, 2023. Amortization expense of customer relationship was included in sales and marketing in the condensed consolidated statements of operations, and was not significant for the three and six months ended July 31, 2023. Estimated future amortization expense as of July 31, 2023 is as follows (in thousands): Year ending January 31, Amount 2024 (remaining six months) $ 1,417 2025 2,833 2026 2,833 2027 2,612 2028 2,500 2029 and thereafter 833 Total $ 13,028

Revenue and Performance Obligat

Revenue and Performance Obligations	6 Months Ended
	Jul. 31, 2023
Disaggregation of Revenue [Abstract]
Revenue and Performance Obligations	5. Revenue and Performance Obligations Disaggregation of revenue The following table presents revenue by category (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Amount % of Total Amount % of Total Amount % of Total Amount % of Total License $ 16,724 12 % $ 15,338 13 % $ 31,882 11 % $ 25,682 12 % Support 103,997 72 84,257 75 $ 205,910 74 163,465 76 Cloud-hosted services 18,372 13 10,637 9 $ 34,916 12 19,469 9 Total subscription revenue 139,093 97 110,232 97 272,708 97 208,616 97 Professional services and other 4,153 3 3,631 3 8,521 3 6,144 3 Total revenue $ 143,246 100 % $ 113,863 100 % $ 281,229 100 % $ 214,760 100 % The following table summarizes the revenue by region based on the billing address of customers who have contracted to use the Company's products and services (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Amount % of Total Amount % of Total Amount % of Total Amount % of Total United States $ 100,057 70 % $ 83,402 73 % $ 198,614 71 % $ 156,192 73 % Rest of the world 43,189 30 30,461 27 82,615 29 58,568 27 Total $ 143,246 100 % $ 113,863 100 % $ 281,229 100 % $ 214,760 100 % No other country, outside of the United States, exceeded 10% of total revenue during the periods presented. Contract Balances Changes in deferred revenue and unbilled accounts receivable were as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Balance, beginning of period $ 276,414 $ 219,928 $ 302,244 $ 223,289 Deferred revenue billings including reclassification to deferred revenue from customer deposits 160,210 121,434 273,256 219,528 Recognition of revenue, net of change in unbilled accounts receivable* (143,183) (114,550) (282,059) (216,005) Balance, end of period $ 293,441 $ 226,812 $ 293,441 $ 226,812 * Reconciliation to revenue reported per consolidated statements of operations: Revenue billed as of the end of the period $ 143,183 $ 114,550 $ 282,059 $ 216,005 Increase (decrease) in total unbilled accounts receivable 63 (687) (830) (1,245) Revenue reported per consolidated statements of operations $ 143,246 $ 113,863 $ 281,229 $ 214,760 Unbilled accounts receivable represents revenue recognized on contracts for which billings have not yet been presented to customers because the amounts were earned but not contractually billable as of the balance sheet date. The unbilled accounts receivable balance is due within one year. As of July 31, 2023 and January 31, 2023, unbilled accounts receivable of approximately $4.1 million and $4.9 million, respectively, were included in accounts receivable on the Company’s condensed consolidated balance sheets. Remaining Performance Obligations (RPOs) The typical stated customer contract term is one year but can range up to three years. RPOs include both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. As of July 31, 2023 and January 31, 2023, the Company had $682.5 million and $647.1 million, respectively, of remaining performance obligations, which is comprised of product and services revenue not yet delivered. As of July 31, 2023 and January 31, 2023, the Company expected to recognize approximately 58% and 58%, respectively, of its remaining performance obligations as revenue over the next 12 months and the remainder thereafter. RPOs exclude customer deposits, which are refundable pre-paid amounts that are expected to be recognized as revenue in future periods. These balances are included in customer deposits in the condensed consolidated balance sheets and are classified as current because contractually customers can cancel these obligations with 30 days written notice. The customer deposit balance is amortized to revenue over the term of the underlying contract as the customer’s right to cancel expires. If no contracts with customers are cancelled, the existing customer deposit balance will be recognized to revenue over the remaining stated term of the underlying contract which may be over the next 12 months or longer as follows (in thousands): As of July 31, 2023 January 31, 2023 Within the next 12 months $ 21,412 $ 22,657 After the next 12 months 4,152 4,042 Total $ 25,564 $ 26,699

Short-term Investments

Short-term Investments	6 Months Ended
	Jul. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Short-term Investments	6. Short-term Investments The following tables summarize the fair values of the Company’s short-term investments (in thousands): As of July 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 224,375 $ — $ (566) $ 223,809 U.S. agency obligations 65,065 — (144) 64,921 Corporate notes and bonds 64,892 13 (236) 64,669 Commercial paper 47,866 — — 47,866 Certificates of deposit 12,829 — — 12,829 Total short-term investments $ 415,027 $ 13 $ (946) $ 414,094 The Company does not hold any marketable securities that have been in a continuous unrealized loss position for over 12 months. For short-term investments with an unrealized loss at July 31, 2023, the unrealized losses were not due to credit-related factors, the Company does not intend to sell these short-term investments and it is more likely than not that the Company will hold these short-term investments until maturity or a recovery of the cost basis. Therefore no allowance for expected credit losses was recorded as of July 31, 2023. Realized gains (losses) were not material for the three and six months ended July 31, 2023. The following table summarizes the contractual maturities of the Company’s short-term investments (in thousands): As of July 31, 2023 Amortized Cost Fair Value Due within one year $ 377,007 $ 376,257 Due after one year through three years 38,020 37,837 Total $ 415,027 $ 414,094

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	7. Fair Value Measurements The following table sets forth the financial assets, measured at fair value, by level within the fair value hierarchy on a recurring basis and indicates the fair value hierarchy of the valuation inputs used to determine such fair value (in thousands): Fair Value Measurement As of July 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets: Cash and Cash equivalents: Cash $ 807,068 $ — $ — $ 807,068 Money market funds Level 1 19,157 — — 19,157 U.S. treasury securities Level 2 499 — — 499 Corporate notes and bonds Level 2 200 — — 200 Commercial paper Level 2 3,094 — — 3,094 Total cash and cash equivalents $ 830,018 $ — $ — $ 830,018 Short-term Investments: U.S. treasury securities Level 2 $ 224,375 $ — $ (566) $ 223,809 U.S. agency obligations Level 2 65,065 — (144) 64,921 Corporate notes and bonds Level 2 64,892 13 (236) 64,669 Commercial paper Level 2 47,866 — — 47,866 Certificates of deposit Level 2 12,829 — — 12,829 Total short-term investments $ 415,027 $ 13 $ (946) $ 414,094 Total Assets $ 1,245,045 $ 13 $ (946) $ 1,244,112 Liabilities: Derivative instruments: Foreign currency forward contracts Level 2 $ — $ — $ 95 $ 95 Total derivative instruments — — 95 95 Total Liabilities $ — $ — $ 95 $ 95 The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): Fair Value Measurement As of January 31, 2023 Level 1 Level 2 Level 3 Total Cash and cash equivalents Money market funds $ 169,904 $ — $ — $ 169,904 Total cash and cash equivalents 169,904 — — 169,904 Total assets measured at fair value $ 169,904 $ — $ — $ 169,904 The Company classifies its highly liquid money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its corporate notes and bonds, U.S. treasury securities, U.S. agency obligations, commercial paper, certificate of deposits and foreign currency forward contracts within Level 2 of the fair value hierarchy because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. As of July 31, 2023, the declines in the market value of the Company's short-term investment portfolio were not driven by credit related factors. During the six months ended July 31, 2023, the Company determined that it does not intend to sell any securities with a decline in market value, and it is more likely than not that the Company will be able to hold these securities until the entire principal has been recovered. Therefore, the Company did not recognize any losses on the short-term investments due to credit related factors. As of July 31, 2023, the total unrealized losses were not material. There were no transfers between fair value measurement levels during the six months ended July 31, 2023.

Derivative Instruments and Hedg

Derivative Instruments and Hedging	6 Months Ended
	Jul. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging	8. Derivative Instruments and Hedging In June 2023, the Company began entering into foreign currency forward contracts to manage its exposure to certain foreign currency exchange risks. The Company’s derivative instruments generally have maturities of 12 months or less. The Company does not use derivative instruments for trading or speculative purposes. As of July 31, 2023, the Company’s foreign currency forward contracts had an aggregate notional amount of $7.8 million. The Company does not have collateral requirements with any of its counterparties. The following table summarizes the fair value of the Company’s derivative instruments on the condensed consolidated balance sheets (in thousands): Balance Sheet Location Fair Value Derivative Liabilities: Foreign currency forward contracts designated as hedging instruments Accrued expenses and other liabilities $ 95 Total derivative liabilities $ 95 The following table presents the activity of foreign currency forward contracts designated as hedging instruments and the impact of these derivatives on AOCI (in thousands): Six Months Ended July 31, 2023 Beginning balance $ — Net losses recognized in other comprehensive income (108) Net losses reclassified from AOCI to earnings 13 Ending balance $ (95) As of July 31, 2023, net unrealized loss included in the balance of accumulated other comprehensive loss related to foreign currency forward contracts designated as hedging instruments was $0.1 million, all of which the Company expects to reclassify from accumulated other comprehensive loss into earnings over the next 12 months. The effect of foreign currency forward contracts were immaterial on the condensed consolidated financials for the three and six months ended July 31, 2023.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Jul. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Balance Sheet Components	9. Balance Sheet Components Other Assets, Non-Current Other assets, non-current are comprised of the following (in thousands): As of July 31, 2023 January 31, 2023 Property and equipment, net $ 29,784 $ 24,594 Operating lease right-of-use assets 11,086 12,560 Other 1,167 902 Total other assets, non-current $ 42,037 $ 38,056 Property and Equipment, Net Property and equipment, net are included in other assets, non-current in the condensed consolidated balance sheets and are comprised of the following (in thousands): Estimated As of July 31, 2023 January 31, 2023 Furniture and fixtures 5 years $ 1,329 $ 1,292 Computers, equipment and software 3 years 580 581 Capitalized internal-use software development costs 5 years 33,942 25,817 Leasehold improvements Shorter of useful life or lease term 5,510 5,138 Construction in progress 54 47 Total property and equipment 41,415 32,875 Less: accumulated depreciation and amortization (11,631) (8,281) Property and equipment, net $ 29,784 $ 24,594 Total depreciation and amortization expense for property and equipment for the three months ended July 31, 2023 and 2022 was $1.8 million and $1.0 million, respectively. Total depreciation and amortization expense for property and equipment for the six months ended July 31, 2023 and 2022 was $3.4 million and $1.9 million, respectively. The Company capitalized $4.3 million and $2.8 million in internal-use software development costs for the three months ended July 31, 2023 and 2022, and $8.1 million and $5.3 million for the six months ended July 31, 2023 and 2022, respectively. Amortization expense associated with internal-use software development costs totaled $1.5 million and $0.8 million for three months ended July 31, 2023 and 2022, respectively, and $2.8 million and $1.4 million for the six months ended July 31, 2023 and 2022. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities are comprised of the following (in thousands): As of July 31, 2023 January 31, 2023 Accrued expenses $ 3,940 $ 4,222 Operating lease liabilities 3,590 3,380 Sales tax payable 1,771 1,480 Accrued income taxes payable 980 1,081 Hedging liabilities 95 — Total accrued expenses and other current liabilities $ 10,376 $ 10,163 Accrued Compensation and Benefits Accrued compensation and benefits are comprised of the following (in thousands): As of July 31, 2023 January 31, 2023 Accrued commissions $ 13,853 $ 16,932 Accrued vacation 21,969 20,614 Accrued payroll and withholding taxes 7,451 11,574 ESPP employee contributions 3,903 4,247 Accrued bonus 3,570 3,220 Other 2,759 2,041 Total accrued compensation and benefits $ 53,505 $ 58,628 Deferred Contract Acquisition Costs The following table summarizes the activity of deferred contract acquisition costs (in thousands): Six Months Ended July 31, 2023 2022 Beginning balance $ 124,098 $ 89,331 Capitalization of contract acquisition costs 30,541 39,668 Amortization of deferred contract acquisition costs (26,390) (19,980) Ending balance $ 128,250 $ 109,019 Deferred contract acquisition costs, current $ 45,329 $ 36,219 Deferred contract acquisition costs, non-current 82,921 72,800 Total deferred contract acquisition costs $ 128,250 $ 109,019 There were no impairment losses recognized for deferred contract acquisition costs during the three and six months ended July 31, 2023 and 2022. Other Liabilities, Non-Current The following table summarizes the activity of other liabilities, non-current (in thousands): As of July 31, 2023 January 31, 2023 Operating lease liabilities, non-current $ 10,245 $ 12,093 Acquisition holdback, non-current 4,046 — Accrued commissions, non-current 821 713 Total other liabilities, non-current $ 15,112 $ 12,806

Leases

Leases	6 Months Ended
	Jul. 31, 2023
Leases [Abstract]
Leases	10. Leases The Company leases office spaces under noncancelable operating lease agreements, which expire at various dates through 2027. The Company is required to pay property taxes, insurance, and normal maintenance costs for certain of these facilities. Operating lease cost for these leases is recognized on a straight-line basis over the lease term, with variable lease costs recognized in the period incurred. These lease agreements do not contain residual value guarantees or restrictive covenants. Lease costs Lease costs were as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Short-term lease costs $ 184 $ 46 $ 340 $ 145 Operating lease costs 878 878 1,756 1,756 Total lease costs $ 1,062 $ 924 $ 2,096 $ 1,901 Variable lease cost was not significant for the three and six months ended July 31, 2023 and 2022. There were no other lease components for the periods presented. Lease term and discount rate information are summarized as follows: As of July 31, 2023 Weighted average remaining lease terms (in years) 3.7 Weighted average discount rate 3.8 % Future lease payments under noncancelable operating leases on an undiscounted cash flow basis as of July 31, 2023 are as follows (in thousands): Years Ending January 31, Amount 2024 (remaining six months) $ 1,994 2025 4,150 2026 3,734 2027 3,737 2028 1,277 Total minimum lease payments 14,892 Less imputed interest (1,057) Present value of future minimum lease payments 13,835 Less current lease liabilities (3,590) Operating lease liabilities, non-current $ 10,245 Operating lease liabilities are included in accrued expenses and other current liabilities, and non-current lease liabilities are included in other liabilities, non-current, in the condensed consolidated balance sheets. There were no lease related operating right-of-use asset impairment losses in the three and six months ended July 31, 2023 and 2022.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Letter of credit The Company has a total of $1.8 million in letters of credit outstanding as security deposits for the Company’s leased office spaces as of July 31, 2023 and January 31, 2023. Litigation From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims.

Common Stock and Stockholders'

Common Stock and Stockholders' Equity	6 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Common Stock and Stockholders' Equity	12. Common Stock and Stockholders' Equity Common Stock Reserved for Future Issuance The Company reserved shares of common stock for future issuance as follows (in thousands): As of July 31, 2023 January 31, 2023 Options outstanding 8,424 9,315 Restricted stock units outstanding 14,702 11,588 Remaining shares available for future issuance under the 2021 Equity Incentive Plan ("2021 Plans") 25,490 21,466 2021 Employee Stock Purchase Plan ("ESPP") 4,481 3,008 Total 53,097 45,377 Stock Options The following table summarizes stock option activity for the 2021 Plan (shares and aggregate intrinsic value in thousands): Options Outstanding Number of Options Outstanding Weighted- Average Exercise Price Weighted- Average Remaining Contractual Aggregate Intrinsic Value Balance as of January 31, 2023 9,315 $ 1.92 4.6 $ 281,837 Stock options exercised (879) 1.66 24,920 Stock options cancelled/forfeited/expired (12) 22.39 Balance as of July 31, 2023 8,424 1.92 4.2 233,235 Exercisable as of July 31, 2023 8,371 $ 1.84 4.2 $ 232,479 The total grant-date fair value of stock options vested was $0.8 million and $2.8 million during the six months ended July 31, 2023 and 2022. The total intrinsic value of options exercised during the six months ended July 31, 2023 and 2022 were $24.9 million and $59.5 million, respectively. Restricted Stock Units The Company’s summary of restricted stock units ("RSUs") activity under the 2021 Plan is as follows (in thousands): Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at January 31, 2023 11,588 $ 42.48 RSUs granted 6,830 $ 28.93 RSUs released (2,378) $ 35.58 RSUs cancelled (1,338) $ 38.32 Outstanding and unvested at July 31, 2023 14,702 $ 37.67 The total grant-date fair value of RSUs vested was $84.6 million and $64.9 million during the six months ended July 31, 2023 and 2022. Employee Stock Purchase Plan A total of 4,480,939 shares of Class A common stock are available for future issuance under the ESPP as of July 31, 2023. For the six months ended July 31, 2023 and 2022, the Company recognized $6.5 million and $7.3 million of stock-based compensation expense related to the ESPP, respectively. As of July 31, 2023, unrecognized stock-based compensation expense related to the ESPP was approximately $15.9 million, which is expected to be recognized over a weighted-average period of approximately 1.4 years. The Company’s current offering period began December 15, 2022 and is expected to end December 15, 2024. During the six months ended July 31, 2023, employees purchased 426,193 shares of common stock under the ESPP at a purchase price of $23.97 per share, resulting in total cash proceeds of $10.2 million. ESPP employee payroll contributions accrued as of July 31, 2023 were $3.9 million and are reported within accrued compensation and benefits in the consolidated balance sheets. Payroll contributions accrued as of July 31, 2023 will be used to purchase shares at the end of the current purchase period ending on December 15, 2023. Payroll contributions ultimately used to purchase shares will be reclassified as stockholders’ equity on the purchase date. Stock-Based Compensation Expense Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations is as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Cost of support $ 2,844 $ 2,221 $ 5,100 $ 4,180 Cost of cloud-hosted services 557 686 1,166 1,326 Cost of professional services and other 647 652 1,213 1,380 Sales and marketing 15,483 14,421 27,442 28,814 Research and development 12,942 10,507 24,673 25,245 General and administrative 13,646 13,916 26,688 27,717 Stock-based compensation expense, net of amounts capitalized $ 46,119 $ 42,403 $ 86,282 $ 88,662 Capitalized stock-based compensation 1,352 906 2,455 1,788 Total stock-based compensation expense $ 47,471 $ 43,309 $ 88,737 $ 90,450 As of July 31, 2023 and 2022, total unrecognized stock-based compensation expense related to RSUs was approximately $418.4 million and $390.6 million, respectively, which are expected to be recognized over a weighted-average period of approximately 3.1 years and 2.4 years, respectively. As of July 31, 2023, and 2022, total unrecognized stock-based compensation expense related to unvested stock options was approximately $0.5 million and $2.9 million, respectively, which are expected to be recognized over a weighted-average period of approximately 1.2 years and 1.4 years, respectively.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	13. Net Loss Per Share Attributable to Common Stockholders For periods in which there were Class A and Class B shares outstanding, the rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock were identical, except with respect to voting, converting, and transfer rights. Class B common stock has ten votes per share, and Class A common stock has one vote per share. As the liquidation and dividend rights were identical for Class A and Class B common stock, the undistributed earnings would be allocated on a proportionate basis and the resulting net loss per share would, therefore, be the same for both Class A and Class B common stock on an individual or combined basis. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Numerator: Net loss $ (66,315) $ (74,764) $ (119,573) $ (152,981) Denominator: Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic and diluted 192,610 185,212 191,723 184,114 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.34) $ (0.40) $ (0.62) $ (0.83) The following outstanding potentially dilutive shares of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because the impact of including them would have been antidilutive (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Outstanding stock options and restricted stock units 23,126 22,569 23,126 22,569 Share purchase rights under the ESPP 1,188 1,760 1,182 1,373 Class A and Class B common stock subject to repurchase — 1 — 1 Total 24,314 24,330 24,309 23,943

Reduction in Workforce and Rela

Reduction in Workforce and Related Charges	6 Months Ended
	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Reduction in Workforce and Related Charges	14. Reduction In Workforce and Related Charges On June 7, 2023 the Company announced a workforce reduction plan impacting approximately 8% of the Company’s workforce. The workforce reduction plan was intended to increase operational efficiency, decrease costs and increase profitability. As of July 31, 2023, the Company has substantially completed the reduction plan. During the three and six months ended July 31, 2023, the Company incurred $7.2 million of charges, consisting of $5.9 million of employee severance, $0.4 million in payroll taxes, and $0.9 million in other plan-related charges. These charges were recorded within the condensed consolidated statements of operations, of which, $4.3 million was recorded in sales and marketing, $1.7 million in research and development, $0.7 million in general and administrative and the remaining $0.5 million was recorded in cost of revenue for the three and six months ended July 31, 2023. The $7.2 million of cash charges described above were offset by a $2.1 million benefit in stock-based compensation expense, primarily due to reversal of stock-based compensation for amounts that were not vested under the terms and conditions of the original award. As of July 31, 2023, the reduction in workforce liability accrued but not paid totaled $1.0 million, and is included within accrued compensation and benefits in the condensed consolidated balance sheets. Any remaining charges related to the plan are expected to be immaterial to the consolidated financial statements. The following table presents the activity of the reduction in workforce liability for the six months ended July 31, 2023 (in thousands): Workforce Reduction Liability Balance as of January 31, 2023 $ — Charges, excluding stock-based compensation expense 7,185 Payments (6,143) Balance as of July 31, 2023 $ 1,042

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	15. Income Taxes The Company determines its income tax provision for interim periods using an estimate of its annual effective tax rate adjusted for discrete items occurring during the periods presented. The primary difference between the effective tax rate and the federal statutory rate is related to nonrecognition of tax benefits due to valuation allowance established for US federal and state deferred tax assets. The Company recorded an income tax expense of $0.2 million and income tax expense of $0.4 million for the six months ended July 31, 2023 and 2022, respectively. The tax expense for the six months ended July 31, 2023 included a partial release of valuation allowance, of which $0.5 million tax benefit was directly related to the day one impact from the acquisition of BluBracket, Inc. In connection with the BluBracket acquisition, the Company recorded a net deferred tax liability which provides an additional source of taxable income to support the realization of the pre-existing deferred tax assets and, accordingly, during the six months ended July 31, 2023, the Company released a total of $0.5 million of its U.S. valuation allowance. The Company continues to maintain a valuation allowance for its U.S. Federal and state net deferred tax assets. The tax expense for the six months ended July 31, 2023 was primarily due to foreign and US state income tax expense. The Company is subject to income tax in the United States, certain states, and various foreign countries. Due to the history of net operating losses, the Company is subject to United States federal, state, and local examinations by tax authorities for all years since incorporation.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (66,315)	$ (53,258)	$ (74,764)	$ (78,217)	$ (119,573)	$ (152,981)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jul. 31, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Brandon Sweeney [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On June 13, 2023, Brandon Sweeney, our Chief Revenue Officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The plan provides for the sale of an aggregate of up to 120,000 shares of our common stock. The plan will terminate on March 15, 2024, subject to early termination for certain specified events set forth in the plan.
Name	Brandon Sweeney
Title	Chief Revenue Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 13, 2023
Termination Date	March 15, 2024
Arrangement Duration	276 days
Aggregate Available	120,000
Marc Holmes [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On June 23, 2023, Marc Holmes, our Chief Marketing and Business Operations Officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The plan provides for the sale of an aggregate of up to 162,505 shares of our common stock. The actual amount sold will be less based on tax withholdings. The plan will terminate on September 27, 2024, subject to early termination for certain specified events set forth in the plan.
Name	Marc Holmes
Title	Chief Marketing and Business Operations Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 23, 2023
Termination Date	September 27, 2024
Arrangement Duration	462 days
Aggregate Available	162,505
David McJannet [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On July 11, 2023, David McJannet, our Chief Executive Officer, President and Chairman of the Board of Directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The plan provides for the sale of an aggregate of up to 1,480,000 shares of our common stock. The actual amount sold will be less based on tax withholdings. The plan will terminate on October 11, 2024, subject to early termination for certain specified events set forth in the plan.
Name	David McJannet
Title	Chief Executive Officer, President and Chairman of the Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	July 11, 2023
Termination Date	October 11, 2024
Arrangement Duration	458 days
Aggregate Available	1,480,000
Navam Welihinda [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On July 19, 2023, Navam Welihinda, our Chief Financial Officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The plan provides for the sale of an aggregate of up to 162,505 shares of our common stock. The actual amount sold will be less based on tax withholdings. The plan will terminate on October 18, 2024, subject to early termination for certain specified events set forth in the plan.
Name	Navam Welihinda
Title	Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	July 19, 2023
Termination Date	October 18, 2024
Arrangement Duration	457 days
Aggregate Available	162,505
Armon Dadgar [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On July 21, 2023, Armon Dadgar, our Co-Founder, Chief Technology Officer and Director, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The plan provides for the sale of an aggregate of up to 53,020 shares of our common stock. The actual amount sold will be less based on tax withholdings. The plan will terminate on December 31, 2023, subject to early termination for certain specified events set forth in the plan.
Name	Armon Dadgar
Title	Co-Founder, Chief Technology Officer and Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	July 21, 2023
Termination Date	December 31, 2023
Arrangement Duration	163 days
Aggregate Available	53,020

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America ("U.S. GAAP" or "GAAP") and include the accounts of the Company and its wholly owned subsidiaries. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (the "SEC"). The condensed balance sheet data as of January 31, 2023 was derived from the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “2023 Form 10-K”), but does not include all disclosures required by U.S. GAAP. Therefore, these interim condensed consolidated financial statements and accom panying footnotes should be read in conjunction with the Company’s annual consolidated financial statements and related footnotes included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “fiscal 2023 Form 10-K”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, that are, in the opinion of management, necessary for the fair presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity for the interim periods presented. The results of operations for the three and six months ended July 31, 2023 shown in this report are not necessarily indicative of the results to be expected for the full year ending January 31, 2024 or any other period.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting period. Such management estimates include, but are not limited to, the determination of standalone selling prices of the Company’s performance obligations, the estimated period of benefit of deferred contract acquisition costs, the fair value of share-based awards, software development costs, discount rates used for operating leases, goodwill and acquisition-related intangible assets, and the valuation allowance on deferred tax assets and uncertain tax positions. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates.
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss As of July 31, 2023, accumulated other comprehensive loss was comprised of unrealized losses from available-for-sale investments and unrealized losses related to the effective portion of changes in the fair value of foreign currency forward contracts designated as cash flow hedges.
Impairment of Long-Lived Assets	Impairment of Long-Lived AssetsLong-lived assets, such as property and equipment, acquired intangible assets, and capitalized software development costs subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If circumstances require a long-lived asset be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by the asset to its carrying value. If the carrying value of the long-lived asset is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary.
Significant Accounting Policies	Significant Accounting Policies Other than the business combinations, goodwill, short-term investments and derivative instruments and hedging policies described below, there have been no changes to the Company’s significant accounting policies described in the fiscal 2023 Form 10-K that have had a material impact on these condensed consolidated financial statements and related notes.
Business Combinations	Business Combinations The Company recognizes identifiable assets acquired and liabilities assumed at their acquisition date fair value. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions as a part of the purchase price allocation process to accurately value assets acquired and liabilities assumed at the acquisition date, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill to the extent that the Company identifies adjustments to the preliminary purchase price allocation. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s consolidated statements of operations. There has been no such adjustment as of July 31, 2023.
Goodwill	Goodwill Goodwill represents the excess of the purchase price of an acquired business over the fair value of the underlying net tangible and intangible assets. Goodwill is evaluated for impairment annually in the fourth quarter of the Company’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill, or a significant decrease in expected cash flows.
Short-term Investments	Short-term Investments The Company’s short-term investments consist of U.S. treasury securities, corporate notes and bonds, U.S. agency obligations, commercial paper, and certificates of deposit. The Company determines the appropriate classification of its short-term investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company has classified and accounted for its short-term investments as available-for-sale securities. The Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its short-term investments, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. Available-for-sale securities are recorded at fair value each reporting period, and are adjusted for amortization of premiums and accretion of discounts to maturity and such amortization and accretion are included in interest income in the condensed consolidated statements of operations. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the condensed consolidated statements of operations. Unrealized gains are reported as a separate component of accumulated other comprehensive loss on the condensed consolidated balance sheets until realized. For available-for-sale securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the condensed consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the condensed consolidated balance sheets with a corresponding charge in other income (expense), net in the condensed consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive loss.
Derivative Instruments and Hedging	Derivative Instruments and Hedging The Company enters into foreign currency forward contracts with certain financial institutions to mitigate the impact of foreign currency fluctuations on future cash flows and earnings. All of the Company’s foreign currency forward contracts are designated as cash flow hedges. The foreign currency forward contracts generally have maturities of 12 months or less. The Company recognizes all forward contracts as either assets or liabilities on the consolidated balance sheets at fair value. Gains and losses on each forward contract are initially reported as a component of accumulated other comprehensive income (loss) (“AOCI”), and subsequently reclassified into cost of revenue or operating expense in the same period, or periods, during which the hedged transaction affects earnings. The Company evaluates the effectiveness of its cash flow hedges on a quarterly basis and does not exclude any component of the changes in fair value of the derivative instruments for effectiveness testing purposes. The Company classifies cash flows related to its cash flow hedges as operating activities in its consolidated statements of cash flows. The Company does not have collateral requirements with any of its counterparties. The Company does not use derivative instruments for trading or speculative purposes.

Business Combinations (Tables)

Business Combinations (Tables)	6 Months Ended
	Jul. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Summary of Purchase Price Allocation	The following table presents the purchase price allocation related to the acquisition (in thousands): As of July, 31, 2023 Net liabilities $ (224) Developed technology 12,500 Customer relationship 1,000 Deferred tax liabilities (482) Goodwill 12,265 Total purchase consideration $ 25,059

Goodwill and Acquisition-rela_2

Goodwill and Acquisition-related Intangible Assets, Net (Tables)	6 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	During the six months ended July 31, 2023, changes in goodwill consisted of the following (in thousands): Balance as of January 31, 2023 $ — BluBracket, Inc. (Note 3) 12,265 Balance as of July 31, 2023 $ 12,265
Schedule of Finite-Lived Intangible Assets	Acquisition-related intangible assets, net consisted of the following as of July 31, 2023 (in thousands except for useful life): Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful Life Developed technology $ 12,500 $ 417 $ 12,083 4.8 Customer relationship $ 1,000 $ 55 $ 945 2.8
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Estimated future amortization expense as of July 31, 2023 is as follows (in thousands): Year ending January 31, Amount 2024 (remaining six months) $ 1,417 2025 2,833 2026 2,833 2027 2,612 2028 2,500 2029 and thereafter 833 Total $ 13,028

Revenue and Performance Oblig_2

Revenue and Performance Obligations (Tables)	6 Months Ended
	Jul. 31, 2023
Disaggregation of Revenue [Abstract]
Summary of Revenue Disaggregated by Category	The following table presents revenue by category (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Amount % of Total Amount % of Total Amount % of Total Amount % of Total License $ 16,724 12 % $ 15,338 13 % $ 31,882 11 % $ 25,682 12 % Support 103,997 72 84,257 75 $ 205,910 74 163,465 76 Cloud-hosted services 18,372 13 10,637 9 $ 34,916 12 19,469 9 Total subscription revenue 139,093 97 110,232 97 272,708 97 208,616 97 Professional services and other 4,153 3 3,631 3 8,521 3 6,144 3 Total revenue $ 143,246 100 % $ 113,863 100 % $ 281,229 100 % $ 214,760 100 %
Summary of Revenue by Region Based on the Billing Address of Customers	The following table summarizes the revenue by region based on the billing address of customers who have contracted to use the Company's products and services (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Amount % of Total Amount % of Total Amount % of Total Amount % of Total United States $ 100,057 70 % $ 83,402 73 % $ 198,614 71 % $ 156,192 73 % Rest of the world 43,189 30 30,461 27 82,615 29 58,568 27 Total $ 143,246 100 % $ 113,863 100 % $ 281,229 100 % $ 214,760 100 %
Summary of Changes in Deferred Revenue and Unbilled Accounts Receivable	Changes in deferred revenue and unbilled accounts receivable were as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Balance, beginning of period $ 276,414 $ 219,928 $ 302,244 $ 223,289 Deferred revenue billings including reclassification to deferred revenue from customer deposits 160,210 121,434 273,256 219,528 Recognition of revenue, net of change in unbilled accounts receivable* (143,183) (114,550) (282,059) (216,005) Balance, end of period $ 293,441 $ 226,812 $ 293,441 $ 226,812 * Reconciliation to revenue reported per consolidated statements of operations: Revenue billed as of the end of the period $ 143,183 $ 114,550 $ 282,059 $ 216,005 Increase (decrease) in total unbilled accounts receivable 63 (687) (830) (1,245) Revenue reported per consolidated statements of operations $ 143,246 $ 113,863 $ 281,229 $ 214,760
Summary of Revenue Recognized Related to Customer Deposit Balance	If no contracts with customers are cancelled, the existing customer deposit balance will be recognized to revenue over the remaining stated term of the underlying contract which may be over the next 12 months or longer as follows (in thousands): As of July 31, 2023 January 31, 2023 Within the next 12 months $ 21,412 $ 22,657 After the next 12 months 4,152 4,042 Total $ 25,564 $ 26,699

Short-term Investments (Tables)

Short-term Investments (Tables)	6 Months Ended
	Jul. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Summary of Fair Value of Short-term Investments	The following tables summarize the fair values of the Company’s short-term investments (in thousands): As of July 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 224,375 $ — $ (566) $ 223,809 U.S. agency obligations 65,065 — (144) 64,921 Corporate notes and bonds 64,892 13 (236) 64,669 Commercial paper 47,866 — — 47,866 Certificates of deposit 12,829 — — 12,829 Total short-term investments $ 415,027 $ 13 $ (946) $ 414,094
Summary of Contractual Maturities	The following table summarizes the contractual maturities of the Company’s short-term investments (in thousands): As of July 31, 2023 Amortized Cost Fair Value Due within one year $ 377,007 $ 376,257 Due after one year through three years 38,020 37,837 Total $ 415,027 $ 414,094

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis	The following table sets forth the financial assets, measured at fair value, by level within the fair value hierarchy on a recurring basis and indicates the fair value hierarchy of the valuation inputs used to determine such fair value (in thousands): Fair Value Measurement As of July 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets: Cash and Cash equivalents: Cash $ 807,068 $ — $ — $ 807,068 Money market funds Level 1 19,157 — — 19,157 U.S. treasury securities Level 2 499 — — 499 Corporate notes and bonds Level 2 200 — — 200 Commercial paper Level 2 3,094 — — 3,094 Total cash and cash equivalents $ 830,018 $ — $ — $ 830,018 Short-term Investments: U.S. treasury securities Level 2 $ 224,375 $ — $ (566) $ 223,809 U.S. agency obligations Level 2 65,065 — (144) 64,921 Corporate notes and bonds Level 2 64,892 13 (236) 64,669 Commercial paper Level 2 47,866 — — 47,866 Certificates of deposit Level 2 12,829 — — 12,829 Total short-term investments $ 415,027 $ 13 $ (946) $ 414,094 Total Assets $ 1,245,045 $ 13 $ (946) $ 1,244,112 Liabilities: Derivative instruments: Foreign currency forward contracts Level 2 $ — $ — $ 95 $ 95 Total derivative instruments — — 95 95 Total Liabilities $ — $ — $ 95 $ 95 The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): Fair Value Measurement As of January 31, 2023 Level 1 Level 2 Level 3 Total Cash and cash equivalents Money market funds $ 169,904 $ — $ — $ 169,904 Total cash and cash equivalents 169,904 — — 169,904 Total assets measured at fair value $ 169,904 $ — $ — $ 169,904

Derivative Instruments and He_2

Derivative Instruments and Hedging (Tables)	6 Months Ended
	Jul. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of the Fair Value of Derivative Instruments	The following table summarizes the fair value of the Company’s derivative instruments on the condensed consolidated balance sheets (in thousands): Balance Sheet Location Fair Value Derivative Liabilities: Foreign currency forward contracts designated as hedging instruments Accrued expenses and other liabilities $ 95 Total derivative liabilities $ 95
Schedule of Derivatives and the Impact on AOCI	The following table presents the activity of foreign currency forward contracts designated as hedging instruments and the impact of these derivatives on AOCI (in thousands): Six Months Ended July 31, 2023 Beginning balance $ — Net losses recognized in other comprehensive income (108) Net losses reclassified from AOCI to earnings 13 Ending balance $ (95)

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Jul. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Summary of Other Assets Non-current	Other assets, non-current are comprised of the following (in thousands): As of July 31, 2023 January 31, 2023 Property and equipment, net $ 29,784 $ 24,594 Operating lease right-of-use assets 11,086 12,560 Other 1,167 902 Total other assets, non-current $ 42,037 $ 38,056
Summary of Property and Equipment, Net	Property and equipment, net are included in other assets, non-current in the condensed consolidated balance sheets and are comprised of the following (in thousands): Estimated As of July 31, 2023 January 31, 2023 Furniture and fixtures 5 years $ 1,329 $ 1,292 Computers, equipment and software 3 years 580 581 Capitalized internal-use software development costs 5 years 33,942 25,817 Leasehold improvements Shorter of useful life or lease term 5,510 5,138 Construction in progress 54 47 Total property and equipment 41,415 32,875 Less: accumulated depreciation and amortization (11,631) (8,281) Property and equipment, net $ 29,784 $ 24,594
Summary of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities are comprised of the following (in thousands): As of July 31, 2023 January 31, 2023 Accrued expenses $ 3,940 $ 4,222 Operating lease liabilities 3,590 3,380 Sales tax payable 1,771 1,480 Accrued income taxes payable 980 1,081 Hedging liabilities 95 — Total accrued expenses and other current liabilities $ 10,376 $ 10,163
Summary of Accrued Compensation and Benefits	Accrued compensation and benefits are comprised of the following (in thousands): As of July 31, 2023 January 31, 2023 Accrued commissions $ 13,853 $ 16,932 Accrued vacation 21,969 20,614 Accrued payroll and withholding taxes 7,451 11,574 ESPP employee contributions 3,903 4,247 Accrued bonus 3,570 3,220 Other 2,759 2,041 Total accrued compensation and benefits $ 53,505 $ 58,628
Summary of Activity of Deferred Contract Acquisition Costs	The following table summarizes the activity of deferred contract acquisition costs (in thousands): Six Months Ended July 31, 2023 2022 Beginning balance $ 124,098 $ 89,331 Capitalization of contract acquisition costs 30,541 39,668 Amortization of deferred contract acquisition costs (26,390) (19,980) Ending balance $ 128,250 $ 109,019 Deferred contract acquisition costs, current $ 45,329 $ 36,219 Deferred contract acquisition costs, non-current 82,921 72,800 Total deferred contract acquisition costs $ 128,250 $ 109,019
Schedule of Other Liabilities, Non-current	The following table summarizes the activity of other liabilities, non-current (in thousands): As of July 31, 2023 January 31, 2023 Operating lease liabilities, non-current $ 10,245 $ 12,093 Acquisition holdback, non-current 4,046 — Accrued commissions, non-current 821 713 Total other liabilities, non-current $ 15,112 $ 12,806

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jul. 31, 2023
Leases [Abstract]
Schedule of Lease Costs	Lease costs were as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Short-term lease costs $ 184 $ 46 $ 340 $ 145 Operating lease costs 878 878 1,756 1,756 Total lease costs $ 1,062 $ 924 $ 2,096 $ 1,901
Summary of Lease Term and Discount Rate	Lease term and discount rate information are summarized as follows: As of July 31, 2023 Weighted average remaining lease terms (in years) 3.7 Weighted average discount rate 3.8 %
Schedule of Future Lease Payments	Future lease payments under noncancelable operating leases on an undiscounted cash flow basis as of July 31, 2023 are as follows (in thousands): Years Ending January 31, Amount 2024 (remaining six months) $ 1,994 2025 4,150 2026 3,734 2027 3,737 2028 1,277 Total minimum lease payments 14,892 Less imputed interest (1,057) Present value of future minimum lease payments 13,835 Less current lease liabilities (3,590) Operating lease liabilities, non-current $ 10,245

Common Stock and Stockholders_2

Common Stock and Stockholders' Equity (Tables)	6 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Schedule of Reserved Shares of Common Stock for Future Issuance	The Company reserved shares of common stock for future issuance as follows (in thousands): As of July 31, 2023 January 31, 2023 Options outstanding 8,424 9,315 Restricted stock units outstanding 14,702 11,588 Remaining shares available for future issuance under the 2021 Equity Incentive Plan ("2021 Plans") 25,490 21,466 2021 Employee Stock Purchase Plan ("ESPP") 4,481 3,008 Total 53,097 45,377
Schedule of Stock Option Activity	The following table summarizes stock option activity for the 2021 Plan (shares and aggregate intrinsic value in thousands): Options Outstanding Number of Options Outstanding Weighted- Average Exercise Price Weighted- Average Remaining Contractual Aggregate Intrinsic Value Balance as of January 31, 2023 9,315 $ 1.92 4.6 $ 281,837 Stock options exercised (879) 1.66 24,920 Stock options cancelled/forfeited/expired (12) 22.39 Balance as of July 31, 2023 8,424 1.92 4.2 233,235 Exercisable as of July 31, 2023 8,371 $ 1.84 4.2 $ 232,479
Schedule of Restricted Stock Units (RSUs") Activity	The Company’s summary of restricted stock units ("RSUs") activity under the 2021 Plan is as follows (in thousands): Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at January 31, 2023 11,588 $ 42.48 RSUs granted 6,830 $ 28.93 RSUs released (2,378) $ 35.58 RSUs cancelled (1,338) $ 38.32 Outstanding and unvested at July 31, 2023 14,702 $ 37.67
Summary of Stock-Based Compensation Expense	Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations is as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Cost of support $ 2,844 $ 2,221 $ 5,100 $ 4,180 Cost of cloud-hosted services 557 686 1,166 1,326 Cost of professional services and other 647 652 1,213 1,380 Sales and marketing 15,483 14,421 27,442 28,814 Research and development 12,942 10,507 24,673 25,245 General and administrative 13,646 13,916 26,688 27,717 Stock-based compensation expense, net of amounts capitalized $ 46,119 $ 42,403 $ 86,282 $ 88,662 Capitalized stock-based compensation 1,352 906 2,455 1,788 Total stock-based compensation expense $ 47,471 $ 43,309 $ 88,737 $ 90,450

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Summary of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Numerator: Net loss $ (66,315) $ (74,764) $ (119,573) $ (152,981) Denominator: Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic and diluted 192,610 185,212 191,723 184,114 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.34) $ (0.40) $ (0.62) $ (0.83)
Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share	The following outstanding potentially dilutive shares of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because the impact of including them would have been antidilutive (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Outstanding stock options and restricted stock units 23,126 22,569 23,126 22,569 Share purchase rights under the ESPP 1,188 1,760 1,182 1,373 Class A and Class B common stock subject to repurchase — 1 — 1 Total 24,314 24,330 24,309 23,943

Reduction in Workforce and Re_2

Reduction in Workforce and Related Charges (Tables)	6 Months Ended
	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Summary of Restructuring Liabilities	The following table presents the activity of the reduction in workforce liability for the six months ended July 31, 2023 (in thousands): Workforce Reduction Liability Balance as of January 31, 2023 $ — Charges, excluding stock-based compensation expense 7,185 Payments (6,143) Balance as of July 31, 2023 $ 1,042

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) $ in Thousands	Jul. 31, 2023 USD ($)
Accounting Policies [Abstract]
Goodwill impairment	$ 0

Business Combinations - Additio

Business Combinations - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
	Jun. 02, 2023	Jul. 31, 2023	Jul. 31, 2023
Developed technology
Business Acquisition [Line Items]
Weighted average useful life			4 years 9 months 18 days
Customer relationship
Business Acquisition [Line Items]
Weighted average useful life			2 years 9 months 18 days
BluBracket
Business Acquisition [Line Items]
Purchase price	$ 25,100
Liabilities incurred	$ 4,000
Liabilities incurred, period	14 months
Liabilities incurred, due within one year	$ 200
Retention agreement, maximum payment	$ 5,000
Compensation expense		$ 400	$ 400
Acquisition related costs		$ 500	$ 500
BluBracket | Developed technology
Business Acquisition [Line Items]
Weighted average useful life	5 years
Intangible assets acquired	$ 12,500
BluBracket | Customer relationship
Business Acquisition [Line Items]
Weighted average useful life	3 years
Intangible assets acquired	$ 1,000

Business Combinations - Summary

Business Combinations - Summary of Business Combination (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jun. 02, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Goodwill	$ 12,265		$ 0
BluBracket
Business Acquisition [Line Items]
Net liabilities		$ (224)
Deferred tax liabilities		(482)
Goodwill		12,265
Total purchase consideration		25,059
Developed technology | BluBracket
Business Acquisition [Line Items]
Intangible assets acquired		12,500
Customer relationship | BluBracket
Business Acquisition [Line Items]
Intangible assets acquired		$ 1,000

Goodwill and Acquisition-rela_3

Goodwill and Acquisition-related Intangible Assets, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2023	Jun. 02, 2023	Jan. 31, 2023
Goodwill [Line Items]
Goodwill	$ 12,265	$ 12,265		$ 0
Developed technology
Goodwill [Line Items]
Accumulated Amortization	$ 500	$ 500
BluBracket
Goodwill [Line Items]
Goodwill			$ 12,265
BluBracket | Customer relationship
Goodwill [Line Items]
Intangible assets acquired			1,000
BluBracket | Developed technology
Goodwill [Line Items]
Intangible assets acquired			$ 12,500

Goodwill and Acquisition-rela_4

Goodwill and Acquisition-related Intangible Assets, Net - Schedule of Goodwill (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2023 USD ($)
Goodwill [Roll Forward]
Balance as of January 31, 2023	$ 0
Bluebracket, Inc	12,265
Balance as of July 31, 2023	$ 12,265

Goodwill and Acquisition-rela_5

Goodwill and Acquisition-related Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands		6 Months Ended
	Jun. 02, 2023	Jul. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Net Carrying Amount		$ 13,028
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		12,500
Accumulated Amortization		417
Net Carrying Amount		$ 12,083
Weighted Average Remaining Useful Life (in years)		4 years 9 months 18 days
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 1,000
Accumulated Amortization		55
Net Carrying Amount		$ 945
Weighted Average Remaining Useful Life (in years)		2 years 9 months 18 days
BluBracket | Developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	5 years
BluBracket | Customer relationship
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	3 years

Goodwill and Acquisition-rela_6

Goodwill and Acquisition-related Intangible Assets, Net - Schedule of Amortization Expense (Details) $ in Thousands	Jul. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (remaining six months)	$ 1,417
2025	2,833
2026	2,833
2027	2,612
2028	2,500
2029 and thereafter	833
Net Carrying Amount	$ 13,028

Revenue and Performance Oblig_3

Revenue and Performance Obligations - Summary of Revenue Disaggregated by Category (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Disaggregation Of Revenue [Line Items]
Amount	$ 143,246	$ 113,863	$ 281,229	$ 214,760
% of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	100%	100%	100%	100%
Subscription revenue
Disaggregation Of Revenue [Line Items]
Amount	$ 139,093	$ 110,232	$ 272,708	$ 208,616
Subscription revenue | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	97%	97%	97%	97%
Subscription revenue | License
Disaggregation Of Revenue [Line Items]
Amount	$ 16,724	$ 15,338	$ 31,882	$ 25,682
Subscription revenue | License | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	12%	13%	11%	12%
Subscription revenue | Support
Disaggregation Of Revenue [Line Items]
Amount	$ 103,997	$ 84,257	$ 205,910	$ 163,465
Subscription revenue | Support | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	72%	75%	74%	76%
Subscription revenue | Cloud-hosted services
Disaggregation Of Revenue [Line Items]
Amount	$ 18,372	$ 10,637	$ 34,916	$ 19,469
Subscription revenue | Cloud-hosted services | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	13%	9%	12%	9%
Professional services and other
Disaggregation Of Revenue [Line Items]
Amount	$ 4,153	$ 3,631	$ 8,521	$ 6,144
Professional services and other | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	3%	3%	3%	3%

Revenue and Performance Oblig_4

Revenue and Performance Obligations - Summary of Revenue by Region Based on the Billing Address of Customers (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 143,246	$ 113,863	$ 281,229	$ 214,760
% of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	100%	100%	100%	100%
United States
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 100,057	$ 83,402	$ 198,614	$ 156,192
United States | % of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	70%	73%	71%	73%
Rest of the world
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 43,189	$ 30,461	$ 82,615	$ 58,568
Rest of the world | % of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	30%	27%	29%	27%

Revenue and Performance Oblig_5

Revenue and Performance Obligations - Changes in Deferred Revenue and Unbilled Accounts Receivable (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Contract With Customer, Change In Contract With Customer, Asset, And Liability [Roll Forward]
Balance, beginning of period	$ 276,414	$ 219,928	$ 302,244	$ 223,289
Deferred revenue billings including reclassification to deferred revenue from customer deposits	160,210	121,434	273,256	219,528
Recognition of revenue, net of change in unbilled accounts receivable	(143,183)	(114,550)	(282,059)	(216,005)
Balance, end of period	293,441	226,812	293,441	226,812
* Reconciliation to revenue reported per consolidated statements of operations:
Revenue billed as of the end of the period	143,183	114,550	282,059	216,005
Increase (decrease) in total unbilled accounts receivable	63	(687)	(830)	(1,245)
Revenue reported per consolidated statements of operations	$ 143,246	$ 113,863	$ 281,229	$ 214,760

Revenue and Performance Oblig_6

Revenue and Performance Obligations - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended
	Jul. 31, 2023	Jan. 31, 2023
Disaggregation Of Revenue [Line Items]
Unbilled accounts receivable balance in due	1 year
Unbilled accounts receivable	$ 4.1	$ 4.9
Remaining performance obligations	$ 682.5	$ 647.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Disaggregation Of Revenue [Line Items]
Remaining performance obligations, percentage		58%
Revenue remaining performance obligation, expected timing of satisfaction, period		12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-08-01
Disaggregation Of Revenue [Line Items]
Remaining performance obligations, percentage	58%
Revenue remaining performance obligation, expected timing of satisfaction, period	12 months
Minimum
Disaggregation Of Revenue [Line Items]
Revenue, performance obligation, contract term	1 year
Maximum
Disaggregation Of Revenue [Line Items]
Revenue, performance obligation, contract term	3 years

Revenue and Performance Oblig_7

Revenue and Performance Obligations - Summary of Revenue Recognized Related to Customer Deposit Balance (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Disaggregation of Revenue [Abstract]
Within the next 12 months	$ 21,412	$ 22,657
After the next 12 months	4,152	4,042
Total	$ 25,564	$ 26,699

Short-term Investments - Summar

Short-term Investments - Summary of Fair Value of Short-term Investments (Details) $ in Thousands	Jul. 31, 2023 USD ($)
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 415,027
Gross Unrealized Gains	13
Gross Unrealized Losses	(946)
Estimated Fair Value	414,094
U.S. treasury securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	224,375
Gross Unrealized Gains	0
Gross Unrealized Losses	(566)
Estimated Fair Value	223,809
U.S. agency obligations
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	65,065
Gross Unrealized Gains	0
Gross Unrealized Losses	(144)
Estimated Fair Value	64,921
Corporate notes and bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	64,892
Gross Unrealized Gains	13
Gross Unrealized Losses	(236)
Estimated Fair Value	64,669
Commercial paper
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	47,866
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	47,866
Certificates of deposit
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	12,829
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	$ 12,829

Short-term Investments - Additi

Short-term Investments - Additional Information (Details)	Jul. 31, 2023 USD ($)
Investments, Debt and Equity Securities [Abstract]
Allowance for expected credit losses	$ 0

Short-term Investments - Summ_2

Short-term Investments - Summary of Contractual Maturities (Details) $ in Thousands	Jul. 31, 2023 USD ($)
Amortized Cost
Due within one year	$ 377,007
Due after one year through three years	38,020
Amortized Cost	415,027
Fair Value
Due within one year	376,257
Due after one year through three years	37,837
Estimated Fair Value	$ 414,094

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value, by Level Within the Fair Value Hierarchy on a Recurring Basis (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Cash and Cash equivalents:
Cash and cash equivalents	$ 830,018	$ 1,286,134
Short-term Investments:
Amortized Cost	415,027
Gross Unrealized Gains	13
Gross Unrealized Losses	(946)
Estimated Fair Value	414,094
U.S. treasury securities
Short-term Investments:
Amortized Cost	224,375
Gross Unrealized Gains	0
Gross Unrealized Losses	(566)
Estimated Fair Value	223,809
U.S. agency obligations
Short-term Investments:
Amortized Cost	65,065
Gross Unrealized Gains	0
Gross Unrealized Losses	(144)
Estimated Fair Value	64,921
Corporate notes and bonds
Short-term Investments:
Amortized Cost	64,892
Gross Unrealized Gains	13
Gross Unrealized Losses	(236)
Estimated Fair Value	64,669
Commercial paper
Short-term Investments:
Amortized Cost	47,866
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	47,866
Certificates of deposit
Short-term Investments:
Amortized Cost	12,829
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	12,829
Fair Value, Recurring
Cash and Cash equivalents:
Amortized Cost	830,018
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	830,018
Short-term Investments:
Amortized Cost	415,027
Gross Unrealized Gains	13
Gross Unrealized Losses	(946)
Estimated Fair Value	414,094
Total asset measured at fair value, amortized cost	1,245,045
Total assets measured at fair value, gross unrealized gains	13
Total asset measured at fair value, gross unrealized losses	(946)
Total assets measured at fair value	1,244,112	169,904
Derivative instruments:
Derivative instruments	95
Fair Value, Recurring | Cash
Cash and Cash equivalents:
Amortized Cost	807,068
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	807,068
Level 1 | Fair Value, Recurring
Short-term Investments:
Total assets measured at fair value		169,904
Level 1 | Fair Value, Recurring | Money market funds
Cash and Cash equivalents:
Amortized Cost	19,157
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	19,157
Level 2 | Fair Value, Recurring
Short-term Investments:
Total assets measured at fair value		$ 0
Derivative instruments:
Derivative instruments	95
Level 2 | Fair Value, Recurring | Foreign currency forward contracts
Derivative instruments:
Derivative instruments	95
Level 2 | Fair Value, Recurring | U.S. treasury securities
Cash and Cash equivalents:
Amortized Cost	499
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	499
Level 2 | Fair Value, Recurring | Corporate notes and bonds
Cash and Cash equivalents:
Amortized Cost	200
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	200
Level 2 | Fair Value, Recurring | Commercial paper
Cash and Cash equivalents:
Amortized Cost	3,094
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	3,094
Level 2 | Fair Value, Recurring | U.S. treasury securities
Short-term Investments:
Amortized Cost	224,375
Gross Unrealized Gains	0
Gross Unrealized Losses	(566)
Estimated Fair Value	223,809
Level 2 | Fair Value, Recurring | U.S. agency obligations
Short-term Investments:
Amortized Cost	65,065
Gross Unrealized Gains	0
Gross Unrealized Losses	(144)
Estimated Fair Value	64,921
Level 2 | Fair Value, Recurring | Corporate notes and bonds
Short-term Investments:
Amortized Cost	64,892
Gross Unrealized Gains	13
Gross Unrealized Losses	(236)
Estimated Fair Value	64,669
Level 2 | Fair Value, Recurring | Commercial paper
Short-term Investments:
Amortized Cost	47,866
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	47,866
Level 2 | Fair Value, Recurring | Certificates of deposit
Short-term Investments:
Amortized Cost	12,829
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	$ 12,829

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		$ 169,904
Total assets measured at fair value	$ 1,244,112	169,904
Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		169,904
Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		169,904
Total assets measured at fair value		169,904
Level 1 | Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		169,904
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		0
Total assets measured at fair value		0
Level 2 | Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		0
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		0
Total assets measured at fair value		0
Level 3 | Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	Jul. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Fair value measurement, transfers level 1 to level 2	$ 0

Derivative Instruments and He_3

Derivative Instruments and Hedging - Additional Information (Details) $ in Thousands	Jul. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Accumulated other comprehensive loss related to foreign currency forwards	$ (100)
Foreign Exchange Forward
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 7,800

Derivative Instruments and He_4

Derivative Instruments and Hedging - Summary of the Fair Value of Derivative Instruments (Details) $ in Thousands	Jul. 31, 2023 USD ($)
Derivative Liabilities:
Total derivative liabilities	$ 95
Foreign Exchange Forward | Designated as Hedging Instrument
Derivative Liabilities:
Total derivative liabilities	$ 95

Derivative Instruments and He_5

Derivative Instruments and Hedging - Schedule of Derivatives and the Impact on AOCI (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities [Roll Forward]
Beginning balance	$ 1,205,350
Ending balance	1,184,912
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Derivative Instruments and Hedging Activities [Roll Forward]
Beginning balance	0
Net losses recognized in other comprehensive income	(108)
Net losses reclassified from AOCI to earnings	13
Ending balance	$ (95)

Balance Sheet Components - Summ

Balance Sheet Components - Summary of Other Assets Non-current (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Property and equipment, net	$ 29,784	$ 24,594
Operating lease right-of-use assets	11,086	12,560
Other	1,167	902
Total other assets, non-current	$ 42,037	$ 38,056

Balance Sheet Components - Su_2

Balance Sheet Components - Summary of Property and Equipment Net (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Property Plant And Equipment [Line Items]
Total property and equipment	$ 41,415	$ 32,875
Less: accumulated depreciation and amortization	(11,631)	(8,281)
Property and equipment, net	$ 29,784	24,594
Furniture and fixtures
Property Plant And Equipment [Line Items]
Estimated Useful life	5 years
Total property and equipment	$ 1,329	1,292
Computers, equipment and software
Property Plant And Equipment [Line Items]
Estimated Useful life	3 years
Total property and equipment	$ 580	581
Capitalized internal-use software development costs
Property Plant And Equipment [Line Items]
Estimated Useful life	5 years
Total property and equipment	$ 33,942	25,817
Leasehold improvements
Property Plant And Equipment [Line Items]
Estimated Useful life	Useful Life, Shorter of Lease Term or Asset Utility [Member]
Total property and equipment	$ 5,510	5,138
Construction in progress
Property Plant And Equipment [Line Items]
Total property and equipment	$ 54	$ 47

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Supplemental Balance Sheet Disclosures [Line Items]
Depreciation and amortization expense	$ (1,800,000)	$ (1,000,000)	$ (3,400,000)	$ (1,900,000)
Amortization of capitalized costs	(1,500,000)	(800,000)	(2,800,000)	(1,400,000)
Software capitalized costs	4,300,000	2,800,000	8,100,000	5,300,000
Impairment losses for deferred contract acquisition costs	$ 0	$ 0	$ 0	$ 0

Balance Sheet Components - Su_3

Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Payables and Accruals [Abstract]
Accrued expenses	$ 3,940	$ 4,222
Operating lease liabilities	3,590	3,380
Sales tax payable	1,771	1,480
Accrued income taxes payable	980	1,081
Hedging liabilities	95	0
Total accrued expenses and other current liabilities	$ 10,376	$ 10,163

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Compensation And Benefits [Abstract]
Accrued commissions	$ 13,853	$ 16,932
Accrued vacation	21,969	20,614
Accrued payroll and withholding taxes	7,451	11,574
ESPP employee contributions	3,903	4,247
Accrued bonus	3,570	3,220
Other	2,759	2,041
Total accrued compensation and benefits	$ 53,505	$ 58,628

Balance Sheet Components - Su_4

Balance Sheet Components - Summary of Activity of Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Capitalized Contract Cost, Net, Classified [Roll Forward]
Beginning balance	$ 124,098	$ 89,331
Capitalization of contract acquisition costs	30,541	39,668
Amortization of deferred contract acquisition costs	(26,390)	(19,980)
Ending balance	128,250	109,019
Deferred contract acquisition costs, current	45,329	36,219
Deferred contract acquisition costs, non-current	82,921	72,800
Total deferred contract acquisition costs	$ 128,250	$ 109,019

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Other Liabilities, Non-current (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Operating lease liabilities, non-current	$ 10,245	$ 12,093
Liabilities incurred	4,046	0
Accrued commissions	821	713
Other liabilities, non-current	$ 15,112	$ 12,806

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Leases [Abstract]
Short-term lease costs	$ 184	$ 46	$ 340	$ 145
Operating lease costs	878	878	1,756	1,756
Total lease costs	$ 1,062	$ 924	$ 2,096	$ 1,901

Leases - Summary of Lease Term

Leases - Summary of Lease Term and Discount Rate (Details)	Jul. 31, 2023
Leases [Abstract]
Weighted average remaining lease terms (in years)	3 years 8 months 12 days
Weighted average discount rate	3.80%

Leases - Schedule of Future Lea

Leases - Schedule of Future Lease Payments (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Leases [Abstract]
2024 (remaining six months)	$ 1,994
2025	4,150
2026	3,734
2027	3,737
2028	1,277
Total minimum lease payments	14,892
Less imputed interest	(1,057)
Present value of future minimum lease payments	13,835
Less current lease liabilities	(3,590)	$ (3,380)
Operating lease liabilities, non-current	$ 10,245	$ 12,093

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Leases [Abstract]
Operating right-of-use asset impairment losses	$ 0	$ 0	$ 0	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	Jul. 31, 2023	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding amount	$ 1.8	$ 1.8

Common Stock and Stockholders_3

Common Stock and Stockholders' Equity - Schedule of Reserved Shares of Common Stock for Future Issuance (Details) - shares shares in Thousands	Jul. 31, 2023	Jan. 31, 2023
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	53,097	45,377
2021 Equity Incentive Plan
Class Of Stock [Line Items]
Remaining shares available for future issuance	25,490	21,466
2021 Employee Stock Purchase Plan ("ESPP")
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	4,481	3,008
Options outstanding
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	8,424	9,315
Restricted stock units outstanding
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	14,702	11,588

Common Stock and Stockholders_4

Common Stock and Stockholders' Equity - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended		12 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Aggregate Intrinsic Value
Aggregate intrinsic value, exercised	$ 24,900	$ 59,500
2021 Equity Incentive Plan
Number of Options Outstanding
Beginning balance (in shares)	9,315
Stock options exercised (in shares)	(879)
Stock options cancelled/forfeited/expired (in shares)	(12)
Ending balance (in shares)	8,424		9,315
Number of options outstanding, exercisable (in shares)	8,371
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 1.92
Stock options exercised (in dollars per share)	1.66
Stock options cancelled/forfeited/expired (in dollars per share)	22.39
Ending balance (in dollars per share)	1.92		$ 1.92
Weighted-average exercise price per share, exercisable (in dollars per share)	$ 1.84
Weighted- Average Remaining Contractual Term (in Years)	4 years 2 months 12 days		4 years 7 months 6 days
Weighted Average Remaining Contractual Term, Exercisable (in years)	4 years 2 months 12 days
Aggregate Intrinsic Value
Aggregate intrinsic value	$ 233,235		$ 281,837
Aggregate intrinsic value, exercised	24,920
Aggregate intrinsic value, exercisable	$ 232,479

Common Stock and Stockholders_5

Common Stock and Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total grant-date fair value of stock options vested			$ 800	$ 2,800
Total intrinsic value of options exercised			24,900	59,500
Stock-based compensation expense, net of amounts capitalized	$ 46,119	$ 42,403	86,282	88,662
Unrecognized stock-based compensation expense	500	2,900	$ 500	$ 2,900
Unrecognized stock-based compensation expense, weighted-average period			1 year 2 months 12 days	1 year 4 months 24 days
ESPP employee payroll contributions	$ 53,505		$ 53,505		$ 58,628
2021 Employee Stock Purchase Plan ("ESPP")
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense, net of amounts capitalized			$ 6,500	$ 7,300
Employee stock purchase plan, shares issued (in shares)			426,193
Purchase price per share (dollars per share)	$ 23.97		$ 23.97
Cash proceeds from common stock			$ 10,200
Unrecognized stock-based compensation expense	$ 15,900		$ 15,900
Unrecognized stock-based compensation expense, weighted-average period			1 year 4 months 24 days
ESPP employee payroll contributions	$ 3,900		$ 3,900
2021 Employee Stock Purchase Plan ("ESPP") | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for sale	4,480,939		4,480,939
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant-date fair value of vested shares			$ 84,600	64,900
Unrecognized stock-based compensation expense	$ 418,400	$ 390,600	$ 418,400	$ 390,600
Unrecognized stock-based compensation expense, weighted-average period			3 years 1 month 6 days	2 years 4 months 24 days

Common Stock and Stockholders_6

Common Stock and Stockholders' Equity - Schedule of Restricted Stock Units ("RSUs") Activity (Details) - 2021 Equity Incentive Plan - Restricted Stock Units shares in Thousands	6 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Awards
Beginning balance (in shares) | shares	11,588
RSUs granted (in shares) | shares	6,830
RSUs released (in shares) | shares	(2,378)
RSUs cancelled (in shares) | shares	(1,338)
Ending balance (in shares) | shares	14,702
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 42.48
RSUs granted (in dollars per share) | $ / shares	28.93
RSUs released (in dollars per share) | $ / shares	35.58
RSUs cancelled (in dollars per share) | $ / shares	38.32
Ending balance (in dollars per share) | $ / shares	$ 37.67

Common Stock and Stockholders_7

Common Stock and Stockholders' Equity - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	$ 46,119	$ 42,403	$ 86,282	$ 88,662
Capitalized stock-based compensation	1,352	906	2,455	1,788
Total stock-based compensation expense	47,471	43,309	88,737	90,450
Cost of revenue | Support
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	2,844	2,221	5,100	4,180
Cost of revenue | Cloud-hosted services
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	557	686	1,166	1,326
Cost of revenue | Professional services and other
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	647	652	1,213	1,380
Sales and marketing
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	15,483	14,421	27,442	28,814
Research and development
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	12,942	10,507	24,673	25,245
General and administrative
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	$ 13,646	$ 13,916	$ 26,688	$ 27,717

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)	6 Months Ended
	Jul. 31, 2023 vote
Class A Common Stock
Class Of Stock [Line Items]
Common stock, voting rights	1
Class B Common Stock
Class Of Stock [Line Items]
Common stock, voting rights	10

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Summary of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2023	Jul. 31, 2022
Numerator:
Net loss	$ (66,315)	$ (53,258)	$ (74,764)	$ (78,217)	$ (119,573)	$ (152,981)
Denominator:
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	192,610		185,212		191,723	184,114
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	192,610		185,212		191,723	184,114
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)	$ (0.34)		$ (0.40)		$ (0.62)	$ (0.83)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)	$ (0.34)		$ (0.40)		$ (0.62)	$ (0.83)

Net Loss Per Share Attributab_5

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	24,314	24,330	24,309	23,943
Outstanding stock options and restricted stock units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	23,126	22,569	23,126	22,569
Share purchase rights under the ESPP
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	1,188	1,760	1,182	1,373
Class A and Class B common stock subject to repurchase
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	0	1	0	1

Reduction in Workforce and Re_3

Reduction in Workforce and Related Charges - Additional Information (Details) $ in Thousands		3 Months Ended	6 Months Ended
	Jun. 07, 2023	Jul. 31, 2023 USD ($)	Jul. 31, 2023 USD ($)	Jan. 31, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Workforce reduction percentage	0.08
Restructuring charges		$ 7,200	$ 7,185
Benefit in stock-based compensation expense		2,100	2,100
Restructuring reserve		1,042	1,042	$ 0
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Restructuring charges		4,300	4,300
Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring charges		1,700	1,700
General and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring charges		700	700
Cost of Sales
Restructuring Cost and Reserve [Line Items]
Restructuring charges		500	500
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges		5,900	5,900
Payroll Taxes
Restructuring Cost and Reserve [Line Items]
Restructuring charges		400	400
Other Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 900	$ 900

Reduction in Workforce and Re_4

Reduction in Workforce and Related Charges - Summary of Restructuring Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2023
Restructuring Reserve [Roll Forward]
Beginning balance		$ 0
Charges, excluding stock-based compensation expense	$ 7,200	7,185
Payments		(6,143)
Ending balance	$ 1,042	$ 1,042

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Tax Contingency [Line Items]
Provision (benefit) for income taxes	$ (86)	$ 137	$ 222	$ 422
Partial release of valuation allowance			$ 500